Experience

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Coherus BioSciences, Inc. of $200 million aggregate principal amount of its…

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Natera, Inc. of $287.5 million aggregate principal amount of its 2.25%…

Davis Polk advised the sole book-running manager in connection with the SEC-registered offering by Nevro Corp. of $189.75 million aggregate principal amount of its 2.75% convertible…

Davis Polk advised Morgan Stanley in connection with its SEC-registered global offering of $3 billion aggregate principal amount of fixed-to-floating-rate senior notes due 2031. During the…

Davis Polk advised the lead manager and sole book-runner in connection with an SEC-registered reopened offering by Bank of America Corporation of $2.5 billion aggregate principal amount of…

Davis Polk advised the lead manager and representative of the several joint book-runners in connection with an SEC-registered offering by Bank of America Corporation of CAD550 million…

Davis Polk advised Morgan Stanley in connection with its SEC-registered global offering of $2 billion aggregate principal amount of fixed-to-floating rate senior notes due 2051. During the…

Davis Polk advised the lead manager, sole book-runner and representative of the several underwriters in connection with an SEC-registered offering by Bank of America Corporation of $3…

Davis Polk is advising the financial adviser to Microchip Technology Incorporated in connection with Microchip’s privately negotiated exchanges of $615 million aggregate principal amount of…

Davis Polk advised the joint book-running managers in connection with a Rule 144A offering by Enphase Energy, Inc. of $320 million aggregate principal amount of its 0.25% convertible senior…